Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CVS Health Corp.

www.cvs.com

Latest From CVS Health Corp.

Considering The Value Of Cardiovascular Data And Real World Evidence In Diabetes

Cardiovascular outcomes trials headlined the recent ADA meeting. Scrip spoke with executives from Novo, Boehringer, AstraZeneca and Merck at the conference about the value of CV data and real world evidence in an era when managing diabetes is about much more than lowering blood glucose.

Clinical Trials Drug Safety

Will Epoetin Biosimilar Serve As Non-Medical Switching Case Study?

Analysts expect potential broad uptake of biosimilars in chronic kidney disease treated at dialysis centers, which could lead to patients being switched off Amgen's Epogen.

Biosimilars Advisory Committees

CVS Point-Of-Sale Rebate Program Adopted By 'Several' Payers

Manufacturer rebates can be used to reduce patient cost sharing at point of sale under the PBM's program. There is growing interest in the idea as a solution to lowering drug costs, but the practice could drive up insurance premiums.

Pricing Debate Reimbursement

HHS Action On Drug Pricing: Here's Who Secretary Price Is Listening To

HHS is expected to move ahead with action to address high drug prices following a series of stakeholder roundtables held over the past month.

Pricing Debate Pharmacy Benefit Management
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register